CYC116 inhibits the Aurora Ser/Thr kinases (A, B and C) and the vascular endothelial growth factor receptor 2 (VEGFR2) tyrosine kinase and has been shown to delay tumour growth in vivo mice model48. Here, KDR is linked to neoplasm.